相关实验视频
Updated: Jan 17, 2026

07:02
In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
Published on: August 23, 2019
7.8K
MCC950通过抑制NLRP3介导的IL-1β释放来减轻甲状腺切除术诱导的状行为
Lan-Xin Li1, Wen-Guang Li2, Xiao-Yi Ma3
1Hebei Province Key Laboratory of Integrated Traditional and Western Medicine in Neurological Rehabilitation, China.
International immunopharmacology
|September 14, 2025
概括
研究人员开发了一种新的小鼠模型,用于治疗甲状腺切除术后的恶心和吐 (PONV). 他们将NLRP3确定为关键因素,建议它作为PONV的潜在治疗点.
科学领域:
- 神经科学是一个神经科学.
- 免疫学 免疫学 免疫学
- 手术并发症 手术并发症
背景情况:
- 手术后恶心和吐 (PONV) 是手术后常见的并发症,影响患者的康复.
- 甲状腺手术后的PONV发病率为~30%,对其潜在机制的研究有限.
- 由于缺乏功能性排泄反射,缺乏用于研究PONV的动物模型.
研究的目的:
- 为研究甲状腺切除术后恶心和吐 (PONV) 建立一种动物模型.
- 研究参与甲状腺切除术诱导的状行为 (TIRB) 的分子和神经通路.
- 为了确定PONV的潜在治疗点.
主要方法:
- 建立了甲状腺切除术诱导的状行为 (TIRB) 的小鼠模型.
- 利用转录组学来识别与TIRB相关的上调基因.
- 采用免疫光和qPCR验证基因表达变化.
主要成果:
- 鉴定了NLRP3炎症组分的Interleukin-1β (IL-1β),作为TIRB后显著上调的NLRP3炎症组分.
- 观察到NLRP3表达在后面的区域增加.
- 作为NLRP3抑制剂的MCC950在小鼠中降低了像一样的行为发生率.
结论:
- 与NLRP3相关的分子通路与甲状腺切除术诱导的状行为 (TIRB) 的发生有关.
- NLRP3为管理PONV提供了一个潜在的新疗法标.
相关概念视频
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
589
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
589
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
605
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
605
Skeletal Muscle Relaxants: Therapeutic Uses
918
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
918

